Last reviewed · How we verify
GEN1056
At a glance
| Generic name | GEN1056 |
|---|---|
| Sponsor | Genmab |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of Safety and Antitumor Activity of GEN1056 in Participants With Advanced Solid Tumors (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GEN1056 CI brief — competitive landscape report
- GEN1056 updates RSS · CI watch RSS
- Genmab portfolio CI